Press Releases

Press Releases

TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical Trial

July 30, 2020

TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical Trial

TFF Pharmaceuticals Comments on Research on the Re-formulation of Remdesivir to a Dry Powder Form for COVID-19 Antiviral Treatment

July 29, 2020

TFF Pharmaceuticals Comments on Research on the Re-formulation of Remdesivir to a Dry Powder Form for COVID-19 Antiviral Treatment

UT News: Dry Powder Inhalation Could Be a Potent Tool in COVID-19 Antiviral Treatment

July 28, 2020

UT News: Dry Powder Inhalation Could Be a Potent Tool in COVID-19 Antiviral Treatment

TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder and Topline Data for Voriconazole Inhalation Powder

June 29, 2020

TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder and Topline Data for Voriconazole Inhalation Powder

TFF Pharmaceuticals Receives Orphan Drug Designation for Tacrolimus Inhalation Powder

June 18, 2020

TFF Pharmaceuticals Receives Orphan Drug Designation for Tacrolimus Inhalation Powder

TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

May 14, 2020

TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020

May 7, 2020

TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020

TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting

April 30, 2020

TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting

TFF Pharmaceuticals to Present at April 2020 Virtual Investor Summit

April 17, 2020

TFF Pharmaceuticals to Present at April 2020 Virtual Investor Summit

TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for use of its Thin Film Freezing Technology Platform

April 15, 2020

TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for use of its Thin Film Freezing Technology Platform

Displaying 1 - 10 of 33
Top